MCCORMICK FRANK 4
4 · BridgeBio Pharma, Inc. · Filed Jun 25, 2024
Insider Transaction Report
Form 4
MCCORMICK FRANK
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-06-21+26,014→ 26,014 totalExercise: $27.36Exp: 2034-06-20→ Common Stock (26,014 underlying)
Holdings
- 979,979(indirect: By Trust)
Common Stock
- 120,086
Common Stock
Footnotes (3)
- [F1]Excludes 352,290 shares that were previously held directly by the Reporting Person and were transferred to the Reporting Person's trust account on April 16, 2024.
- [F2]Includes 352,290 shares that were previously held directly by the Reporting Person and were transferred to the Reporting Person's trust account on April 16, 2024.
- [F3]One-third of the shares underlying the stock option will vest each year after June 21, 2024, such that all of the underlying shares will be vested on June 21, 2027, subject to the Reporting Person's continued service on the board of directors of the Issuer.